Understanding Genomic Science Will be Necessary to Prevail in Toxic Tort and Pharmaceutical Litigation

Posted by David Schwartz on Thu, Apr, 28, 2016

Silicone wristbands are being sold as personal exposure monitors to measure the so-called exposome – i.e., every chemical a person is exposed to over the course of a lifetime. Advances in genomic science are transforming our understanding of lung cancer, differentiating lung cancers in asbestos-exposed patients from lung cancer in asbestos unexposed patients. Genomic information is heavily influencing the types of warnings being made for pharmaceutical products.

Read More

Under Fire: Will Homeopathic Remedies be the Next Consumer Fraud Mass Tort?

Posted by Maria-Elena Gorini on Thu, Mar, 31, 2016

Consumer fraud cases have been on the rise over the last decade, including cosmetics, dietary supplements, over-the-counter (OTC) drugs, among others, and have all been under scrutiny of the courts based on the lack of data supporting marketing claims.

Recently, the evidence supporting the efficacy of homeopathic therapies has come under increased scrutiny, making them a perfect target for consumer fraud.

Read More

BAP1 Genomic Mouse Studies Provide Important Clues to the Cause of Malignant Mesothelioma

Posted by David Schwartz on Thu, Mar, 17, 2016

About five years ago, scientists began trying to explain why different individuals seem to have variable susceptibilities to mesothelioma (i.e., why do some individuals develop cancer when exposed to very low levels of asbestos, while others who have been exposed to very high levels of asbestos do not develop cancer?).

Read More

Ovarian Cancer, Genetic Testing and Talcum Powder Litigation

Posted by Giovanni Ciavarra on Fri, Mar, 04, 2016

This article was authored by Giovanni Ciavarra, PhD and Kirk Hartley, Esq. 

Read More

First Asbestos Genetic Susceptibility (BAP1) Trial Now in the Books

Posted by Maria-Elena Gorini on Thu, Mar, 03, 2016

This article was authored by David Schwartz, PhD and Kirk Hartley, Esq.  This post previously appeared on The Goldberg Segalla Asbestos Case Tracker.

Asbestos litigation has now entered the modern era. Namely, the first case involving testimony related to BAP1 mutations has gone to trial in California: the Ortwein case. The trial involved a 50-year-old woman with pleural mesothelioma, represented by the Kazan firm. The defendant at trial was CertainTeed, a building manufacturer, and the case settled shortly before it would have gone to the jury.

Read More

Big Picture Thinking About Headlines Involving “Cancer”: Is Cancer Environmentally-Induced or Due to “Bad Luck”?

Posted by David Schwartz on Mon, Feb, 08, 2016

This article was authored by David Schwartz, PhD and Kirk Hartley, Esq.  This post previously appeared on The Goldberg Segalla Asbestos Case Tracker.

Read More

Will Diacetyl Flavorings in E-Cigarettes be the Next Mass Tort?

Posted by Giovanni Ciavarra on Fri, Jan, 29, 2016

This post also appears on Goldberg Segalla's Product Liability Playbook Blog. This post was co-authored by Giovanni Ciavarra, Ph.D. of Innovative Science Solutions, and Christopher P. Midura of Goldberg Segalla.

Read More

Multiple Factors and Causation in Cancer Litigation: Examples from a Coal Tar Pitch Bladder Cancer Case

Posted by David Schwartz on Wed, Jan, 20, 2016

This article was authored by David Schwartz, PhD and Kirk Hartley, Esq.  This post previously appeared on The Goldberg Segalla Asbestos Case Tracker.

Read More

Pharmacogenomics and Product Liability Claims

Posted by Maria-Elena Gorini on Thu, Jan, 07, 2016

Genomics is a topic of interest that is growing in the news and moving its way into the courtroom. We have been following the impact of genomics on litigation in a variety of areas, including its impact on pharmaceutical product liability litigation.

Read More

E-Cigarette Science: With Emerging Science Comes Junk Science

Posted by Giovanni Ciavarra on Thu, Dec, 10, 2015

This post was authored by Lee Johnson, a freelance writer from the UK. Lee has been published on numerous websites, including the Ashtray Blog, and print magazines. He is currently pursuing a degree in physics. He is also part of the EcigaretteReviewed team.

Read More
Blog Search

Blog Subscription